J. Wacker

445 total citations
18 papers, 286 citations indexed

About

J. Wacker is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, J. Wacker has authored 18 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 8 papers in Obstetrics and Gynecology and 2 papers in Oncology. Recurrent topics in J. Wacker's work include Pregnancy and preeclampsia studies (8 papers), Birth, Development, and Health (6 papers) and Global Maternal and Child Health (3 papers). J. Wacker is often cited by papers focused on Pregnancy and preeclampsia studies (8 papers), Birth, Development, and Health (6 papers) and Global Maternal and Child Health (3 papers). J. Wacker collaborates with scholars based in Germany, Zimbabwe and Burkina Faso. J. Wacker's co-authors include G. Bastert, Thierry Rochat, Michael Schulz, G. Bastert, L. Heilmann, Clemens Bartz, Volker Briese, Hartmut Hopp, B. Schauf and W Rath and has published in prestigious journals such as European Respiratory Journal, Nephrology Dialysis Transplantation and International Journal of Gynecology & Obstetrics.

In The Last Decade

J. Wacker

18 papers receiving 267 citations

Peers

J. Wacker
H.-J. Knopf Germany
Suzanne N. Landi United States
Karen Saljé Germany
K. L. Stuart United States
O F Njokanma Nigeria
J. Wacker
Citations per year, relative to J. Wacker J. Wacker (= 1×) peers Susan W. Andersson

Countries citing papers authored by J. Wacker

Since Specialization
Citations

This map shows the geographic impact of J. Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Wacker more than expected).

Fields of papers citing papers by J. Wacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Wacker. The network helps show where J. Wacker may publish in the future.

Co-authorship network of co-authors of J. Wacker

This figure shows the co-authorship network connecting the top 25 collaborators of J. Wacker. A scholar is included among the top collaborators of J. Wacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Wacker. J. Wacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
3.
Schneeweiß, Andreas, Amparo Ruı́z, Ángel Guerrero, et al.. (2007). Doxorubicin/Pemetrexed Followed by Docetaxel Versus Doxorubicin/Cyclophosphamide Followed by Docetaxel as Neoadjuvant Treatment for Early-Stage Breast Cancer: A Randomized Phase II Trial. Clinical Breast Cancer. 7(7). 555–558. 5 indexed citations
4.
Wacker, J., et al.. (2006). Riboflavin supplementation and preeclampsia. International Journal of Gynecology & Obstetrics. 93(2). 136–137. 5 indexed citations
5.
6.
Wacker, J., Volker Briese, B. Schauf, et al.. (2005). Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. European Journal of Obstetrics & Gynecology and Reproductive Biology. 127(2). 160–165. 28 indexed citations
7.
Rochat, Thierry, et al.. (2005). High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis: Table. 1—. European Respiratory Journal. 26(3). 462–464. 79 indexed citations
8.
Heilmann, L., J. Wacker, & W Rath. (2004). Die Diagnostik und Therapie des Schwangerschaftshochdruckes in Deutschland: Ergebnisse einer Umfrage an deutschen Frauenkliniken. Geburtshilfe und Frauenheilkunde. 64(6). 589–599. 3 indexed citations
9.
Wacker, J., et al.. (2001). Auswirkungen von Urapidil in der antihypertensiven Therapie bei Präeklampsie auf die Neugeborenen. Zentralblatt für Gynäkologie. 123(9). 529–533. 8 indexed citations
10.
Schiesser, Monika, et al.. (1999). [Doppler ultrasound findings in therapy with urapidil].. PubMed. 121(12). 611–6. 2 indexed citations
11.
Grau, Thomas, R. Conradi, J. Wacker, & M. Elena Martı́n. (1999). [Pre-eclampsia and anesthesia].. PubMed. 121(12). 627–30. 1 indexed citations
12.
Wacker, J., et al.. (1998). Seasonal change in the incidence of preeclampsia in Zimbabwe. Acta Obstetricia Et Gynecologica Scandinavica. 77(7). 712–716. 23 indexed citations
13.
Wacker, J.. (1998). Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil. Nephrology Dialysis Transplantation. 13(2). 316–323. 11 indexed citations
14.
Wacker, J., et al.. (1998). Seasonal change in the incidence of preeclampsia in Zimbabwe. Acta Obstetricia Et Gynecologica Scandinavica. 77(7). 712–716. 15 indexed citations
15.
Wacker, J., et al.. (1998). Seasonal change in the incidence of preeclampsia in Zimbabwe.. PubMed. 77(7). 712–6. 36 indexed citations
16.
Wacker, J., et al.. (1996). Maternal mortality in the main referral hospital in The Gambia, West Africa. Tropical Medicine & International Health. 1(5). 710–717. 47 indexed citations
17.
Wacker, J., et al.. (1994). [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].. PubMed. 116(5). 271–3. 7 indexed citations
18.
Stolz, W., et al.. (1991). [Vaginal sonography in the diagnosis of and therapeutic indications in cervical incompetence].. PubMed. 20(5). 675–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026